Found 121 matching trials
Talazoparib Maintenance Therapy in Triple-negative Breast Cancer
PHASE2The investigators propose a randomized phase II clinical trial of talazopar...
Location
Yonsei University College of Medicine
Safety and Oversight of the Individually Tailored Treatment Approach: A Novel Pilot Study
NAThis study is looking at outcomes in people with advanced cancers who have ...
Location
Peter MacCallum Cancer Centre
A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
PHASE2A Single Arm Phase II Trial of BMN 673 for Inoperable, Advanced Endometrial...
Location
Royal Sussex County Hospital
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
PHASE2The purpose of this study is to find out whether talazoparib in combination...
Selinexor & Talazoparib in Advanced Refractory Solid Tumors; Advanced/Metastatic Triple Negative Breast Cancer (START)
PHASE1This is a single arm, open-label, phase I dose finding study, followed by a...
Location
National University Hospital
Telmisartan in Prostate Cancer
PHASE1The goal of this clinical trial is to learn about the tolerability of telmi...
A Study of ZEN003694 and Talazoparib in Patients With Triple Negative Breast Cancer
PHASE2This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Location
Banner MD Anderson Cancer Center
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
PHASE1This phase I trial studies the side effects and best dose of talazoparib in...
Location
Multiple Locations
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
PHASE1The purpose of this study is to determine what the safest dose of talazopar...
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer
PHASE2This purpose of this study is to test if talazoparib is safe and evaluate i...
Location
Stanford University